Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 4:35PM CDT
MXIM: 35.00 (-0.19), AWAY: 32.27 (+0.76), GHL: 42.42 (-0.33), HBHC: 30.03 (+0.25), HWAY: 18.99 (-0.08), DV: 36.49 (+0.22), RGA: 93.16 (+0.14), FET: 21.65 (+0.74), GOOG: 539.36 (+5.39), COF: 81.76 (+0.23), FII: 34.50 (+0.44), MSFT: 42.99 (+0.36), BLDR: 13.00 (-0.09), EFII: 42.55 (+0.56), BCR: 175.09 (+0.24), LSTR: 65.26 (+0.57), ETH: 25.96 (+0.16), QDEL: 23.80 (+0.64), RSG: 39.75 (+0.16), HUBG: 37.84 (+0.04), BGS: 29.77 (-0.18), DGII: 9.40 (+0.11), PFG: 51.73 (+0.73), CPHD: 53.14 (-0.78), NTGR: 33.15 (+0.57), FSL: 41.53 (+0.49), ALTR: 42.78 (-0.46), CB: 99.30 (-0.44), N: 95.42 (+1.53), MTSN: 3.73 (+0.07), JNPR: 24.39 (+0.22), MXWL: 6.94 (-0.13), FR: 20.19 (-0.10), GIMO: 23.51 (+0.29), ELY: 9.83 (-0.23), P: 17.51 (+0.28), S: 5.08 (+0.10), RMD: 73.28 (+0.17), BJRI: 50.54 (-1.00), PEB: 45.45 (-0.08), FICO: 92.00 (-0.15), ETFC: 28.60 (+1.07), HBI: 34.12 (+0.23), CBI: 49.62 (-1.62), AMZN: 389.80 (-1.38), ALGN: 55.94 (-0.21), ACTG: 9.83 (-0.08), HA: 22.02 (-0.20), KN: 21.27 (-0.24), NEM: 22.77 (-0.74), MSCC: 35.98 (-0.16), CYN: 93.19 (+0.06), CVTI: 34.35 (-0.01), RHI: 59.59 (+0.30), QLIK: 33.68 (+0.31), MKTO: 28.84 (+0.98), BAS: 7.88 (+0.07), KLAC: 60.30 (+0.96), MMSI: 18.79 (+0.45)
Quidel to Hold First Quarter 2015 Financial Results Conference Call on April 23, 2015
Marketwired - Thu Apr 09, 3:10PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report first quarter 2015 financial results after market close on Thursday, April 23, 2015.
QDEL: 23.80 (+0.64)
Is Great Basin Scientific Just Another Pump And Dump?
The GeoTeam - Seeking Alpha - Wed Apr 08, 12:57PM CDT
GeoInvesting is currently short Great Basic Scientific (NASDAQ: GBSN ), a rapid diagnostic medical test (Nucleic Acid Assay Testing) firm. We first alerted GeoInvesting premium members that we identified red flags associated with GBSN on March 30,...
GNMK: 10.51 (-0.22), GBSN: 4.98 (+1.44), BDX: 144.33 (-1.24), VIVO: 18.89 (+0.01), QDEL: 23.80 (+0.64), CPHD: 53.14 (-0.78), TTOO: 16.10 (-1.15), QGEN: 24.93 (-0.15), HOLX: 33.26 (-0.07), NSPH: 4.05 (+0.10)
Sell Great Basin Scientific Inc., Penny Stock Newsletter Pumps Don't End Well
Big Banks - at Seeking Alpha - Mon Apr 06, 2:31PM CDT
GNMK: 10.51 (-0.22), GBSN: 4.98 (+1.44), RCAP: 8.49 (-0.08), QDEL: 23.80 (+0.64), CPHD: 53.14 (-0.78), RTGN: 3.67 (-0.27)
FDA clears Quidel parasite test
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 12:56PM CDT
QDEL: 23.80 (+0.64)
Quidel Receives FDA Clearance for Its AmpliVue Trichomonas Assay: A Hand-Held Molecular Diagnostic Test for Trichomoniasis
Marketwired - Tue Mar 17, 12:15PM CDT
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received clearance from the United States Food and Drug Administration (FDA) to market its AmpliVue Trichomonas Assay for the detection of nucleic acids isolated from clinician-collected vaginal swab specimens obtained from symptomatic or asymptomatic female patients. This molecular assay aids in the diagnosis of trichomoniasis, a sexually transmitted disease attributable to infection by the Trichomonas vaginalis parasite.
QDEL: 23.80 (+0.64)
Latest Updates in Healthcare Sector: Special Research on OncoGenex, Oxford Immunotec, Quidel, Response Genetics, and Trinity Biotech
PR Newswire - Tue Mar 10, 7:10AM CDT
Editor Note: For more information about this release, please scroll to bottom.
OGXI: 2.11 (-0.02), RGDX: 0.31 (+0.01), QDEL: 23.80 (+0.64), TRIB: 17.17 (-0.17), OXFD: 13.63 (+0.12)
Quidel's (QDEL) CEO Douglas Bryant on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 11, 8:55PM CST
QDEL: 23.80 (+0.64)
Quidel beats 4Q profit forecasts
Automated Insights - Wed Feb 11, 6:27PM CST
SAN DIEGO (AP) _ Quidel Corp. (QDEL) on Wednesday reported fourth-quarter profit of $7.1 million.
QDEL: 23.80 (+0.64)
Quidel (QDEL) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Feb 11, 3:55PM CST
QDEL: 23.80 (+0.64)
Quidel beats by $0.28, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 3:21PM CST
QDEL: 23.80 (+0.64)
Quidel Reports Fourth Quarter and Full Year 2014 Financial Results
Marketwired - Wed Feb 11, 3:10PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the fourth quarter and year ended December 31, 2014.
QDEL: 23.80 (+0.64)
Should You Buy Quidel (QDEL) Ahead of Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 7:46AM CST
Quidel has a favorable Zacks Rank and an ESP in positive territory, thus investors might want to consider this stock ahead of earnings
QDEL: 23.80 (+0.64)
Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 4:35PM CST
TSLA: 219.44 (+10.03), ITRI: 36.90 (-0.02), PNRA: 181.59 (-2.26), SKX: 75.84 (+1.03), STMP: 67.03 (-1.07), ZEN: 23.61 (-0.19), SLF: 31.98 (+0.21), FET: 21.65 (+0.74), HOS: 20.11 (-0.89), HIVE: 5.31 (+0.11), AEM: 29.09 (-1.50), CAKE: 50.05 (+0.84), AMAT: 22.31 (+0.02), CSCO: 28.62 (-0.07), WFM: 48.60 (-0.37), CJES: 14.02 (-0.23), HNI: 57.58 (+0.70), IO: 2.34 (+0.04), GAS: 50.17 (+0.12), QDEL: 23.80 (+0.64), CSOD: 29.42 (+0.25), EXL: 15.84 (unch), NVDA: 22.31 (+0.25), DDR: 17.93 (+0.12), NTWK: 6.34 (+0.02), AMBR: 9.05 (-0.37), CPA: 108.07 (+0.88), FORR: 36.08 (-0.12), AUY: 3.83 (-0.15), CTL: 36.27 (-0.03), ACHC: 71.98 (-0.47), OII: 57.16 (+2.02), NU: 52.54 (+1.31), CVA: 21.54 (-0.43), PPC: 24.36 (+0.16), REG: 65.64 (-0.01), TAL: 41.62 (-0.19), SWM: 45.50 (+0.33), Z: 99.00 (+1.96), FEYE: 43.67 (+0.18), ABCO: 51.98 (-0.12), TCX: 17.96 (-0.09), DIOD: 28.02 (+0.12), MET: 51.05 (+0.66), SPRT: 1.75 (+0.05), TRIP: 82.71 (+1.43), CYS: 9.09 (-0.04), NSIT: 29.01 (+0.22), TTGT: 11.26 (-0.13), NTAP: 36.14 (+0.14), EFX: 94.19 (-0.29), CRAY: 29.98 (-0.26), LPSN: 9.37 (+0.31), BIDU: 213.37 (+0.52), TSO: 89.53 (+3.65), CXW: 39.36 (+0.02), SCSS: 34.12 (+0.30), EFC: 20.08 (-0.07)
Quidel Down 10.5% Since SmarTrend Downtrend Call (QDEL)
Comtex SmarTrend(R) - Tue Feb 10, 9:19AM CST
SmarTrend identified a Downtrend for Quidel (NASDAQ:QDEL) on January 15th, 2015 at $25.49. In approximately 4 weeks, Quidel has returned 10.50% as of today's recent price of $22.81.
QDEL: 23.80 (+0.64)
Quidel reports February 11
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 9:12PM CST
QDEL: 23.80 (+0.64)
Quidel to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call on February 11, 2015
Marketwired - Wed Jan 28, 5:30PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will release fourth quarter and full year 2014 financial results after market close on Wednesday, February 11, 2015.
QDEL: 23.80 (+0.64)
Quidel to Present at 33rd Annual J.P. Morgan Healthcare Conference
Marketwired - Mon Jan 05, 3:05PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the 33rd Annual J.P. Morgan Healthcare Conference to be held at The Westin St. Francis hotel in San Francisco, California on Wednesday, January 14, 2015.
JPM: 62.94 (+0.63), QDEL: 23.80 (+0.64)
Quidel Receives Simultaneous FDA Clearance and CLIA Waiver for Its Sofia(R) Strep A+ Fluorescent Immunoassay (FIA) via the FDA's New Dual Submission Program
Marketwired - Wed Dec 17, 5:45PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it has received marketing clearance and CLIA waiver by the United States Food and Drug Administration (FDA) for its Sofia Strep A+ Fluorescent Immunoassay (FIA) for the rapid detection of infections by Group A Streptococcus bacteria. These bacteria are the most common cause of bacterial pharyngitis and can also cause rheumatic fever and other potentially serious illnesses.
QDEL: 23.80 (+0.64)
Quidel wins US FDA clearance to market AmpliVue molecular diagnostic test for Bordetella pertussis
M2 - Fri Dec 12, 7:01AM CST
Diagnostic testing company Quidel (NASDAQ:QDEL) revealed on Thursday the receipt of clearance from the US Food and Drug Administration (FDA) to market its AmpliVue Bordetella Assay for the detection of Bordetella pertussi.
QDEL: 23.80 (+0.64)